ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

about

Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study.Role of MicroRNA-103a Targeting ADAM10 in Abdominal Aortic Aneurysm.ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.

P2860

Q37641671-FD1924A2-5AFD-4885-AB5A-0071B7168FA9 Q38867927-A958EDFB-1E09-42C4-9E95-213BA36D07C7 Q48002665-C2F9E80A-3B5F-4CAB-99F7-698BC6936900

P2860

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

Item

http://www.wikidata.org/entity/Q36375417

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@ast

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@en

type

Item

label

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@ast

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@en

prefLabel

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@ast

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@en

P1476

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

@en

P2093

Alfred O Mueck

http://www.w3.org/2001/XMLSchema#string

Bo Ma

http://www.w3.org/2001/XMLSchema#string

Chunhui Jin

http://www.w3.org/2001/XMLSchema#string

Guolei Zhang

http://www.w3.org/2001/XMLSchema#string

Harald Seeger

http://www.w3.org/2001/XMLSchema#string

Huiying Zhang

http://www.w3.org/2001/XMLSchema#string

Qianqian Ma

http://www.w3.org/2001/XMLSchema#string

Xiaohong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The consensus coding sequences of human breast and colorectal cancers

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.

Maternal serum disintegrin and metalloprotease protein-12 in early pregnancy as a potential marker of adverse pregnancy outcomes.

ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling.

Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer.

European cancer mortality predictions for the year 2014.

Cellular roles of ADAM12 in health and disease.

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers

P304

13279-13283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26722530

http://www.w3.org/2001/XMLSchema#string

P921

estrogen-receptor positive breast cancer

P932

4680475

http://www.w3.org/2001/XMLSchema#string

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

about

P2860

P2860

ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932